This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Hidradenitis suppurativa
  • /
  • Guidelines for the management of hidradenitis supp...

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology

Read time: 1 mins
Last updated:30th Apr 2021
Status: Live
Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology


Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease that impacts quality of life substantially. Its prevalence is estimated to be 0·7%. 1 Various pathophysiological hypotheses exist, but there is no therapeutic consensus, which complicates the management of patients with HS.

Therefore, the Centre of Evidence of the French Society of Dermatology initiated a standardized recommendation process for HS.


Read full Guideline